Molecular Beacons for Chlamydia trachomatis Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for sexually transmitted infections like Chlamydia trachomatis lack rapid and affordable point-of-care solutions, leading to significant morbidity and mortality, especially in regions with limited resources.
Innovation Solution
The development of a composition comprising labeled polynucleotides, specifically molecular beacons with fluorophores and quenchers, for rapid and specific detection of Chlamydia trachomatis using nucleic acid amplification techniques like LAMP, which allows for rapid amplification and detection of target sequences in clinical samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If conventional diagnostic methods are used for Chlamydia trachomatis detection, then existing protocols can be followed, but the detection process is slow and not suitable for point-of-care use
Solution Approach 1:
The patent changes the detection parameters by using isothermal amplification (constant temperature around 37°C) instead of conventional thermal cycling PCR, eliminating the need for complex temperature programming and enabling rapid detection within minutes at point-of-care settings
Solution Approach 2:
The patent replaces the mechanical thermal cycling system with a chemical amplification system using LAMP primers and Bst polymerase that operates at constant temperature, substituting complex thermal mechanics with biochemical reactions that proceed rapidly at physiological temperatures
2Productivity
If rapid amplification methods like LAMP are used, then detection speed improves, but the complexity of the assay system increases
Solution Approach 1:
The patent segments the amplification process into distinct functional components: FIP and BIP inner primers for initial amplification, F3 and B3 outer primers for amplification enhancement, and specific molecular beacons for detection, allowing each component to be optimized independently while maintaining overall simplicity
Solution Approach 2:
The patent introduces molecular beacons as intermediary detection probes that specifically bind to the amplified DNA products, serving as a bridge between the amplification reaction and the detection readout, enabling rapid and specific detection without complex instrumentation
3Measurement precision
If sensitive detection probes are used, then measurement precision improves, but the cost of reagents increases
Solution Approach 1:
The patent employs disposable, inexpensive molecular beacon probes that can be discarded after use, replacing expensive, reusable detection systems. The probes are designed for single-use in the amplification reaction, eliminating the need for costly instrument maintenance and calibration while maintaining high detection sensitivity
Solution Approach 2:
The patent uses fluorescent molecular beacons that undergo color/fluorescence changes upon binding to the target DNA sequence, providing a simple visual or instrumental readout that does not require expensive reagents or complex detection chemistry, thereby reducing overall reagent costs while maintaining sensitivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, sensitive, and specific detection of Chlamydia trachomatis in clinical samples, reducing the time to diagnosis and improving public health outcomes by providing a cost-effective point-of-care solution.
Implementation Method 1
a probe capable of hybridizing to the amplified product
Implementation Method 2
the probe comprises a label. In some embodiments, the probe is a labeled polynucleotide. In a preferred implementation, the label is a fluorophore
Data Source
AI summary
The invention provides methods and compositions for the detection of Chlamydia trachomatis in a test sample. Its presence or absence in the sample is determined by nucleic acid based testing methods using primers and/or probes and or molecular beacons that bind to the 23S ribosomal genes or gene transcripts.